Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
Spyros Pournaras(National and Kapodistrian University of Athens), Athanasios Tsakris(National and Kapodistrian University of Athens), Evangelia Dimitroulia(National and Kapodistrian University of Athens), Evangelia Neou(University of Thessaly), Georgia Vrioni(National and Kapodistrian University of Athens), Aggeliki Poulou(National and Kapodistrian University of Athens), John Dendrinos(National and Kapodistrian University of Athens)
Cited by 162
Related Papers
Data-based analysis, modelling and forecasting of the COVID-19 outbreak
|PLoS ONE|2020|965
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
|International Journal of Antimicrobial Agents|2012|502
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
|Clinical Microbiology and Infection|2011|441
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
|Clinical Microbiology and Infection|2010|349